Retinoblastoma Patient Clinical Database and Tissue Repository
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Children's Hospital Los Angeles
- Study ID
- NCT04959097
- Status
- Recruiting
Conditions
- Retinoblastoma
- Retinoblastoma Bilateral
- Retinoblastoma Unilateral
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Years - 18 Years
- Healthy Volunteers
- Not accepted
Study Details
Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB is diagnosed without a biopsy; tumor can only be studied once an eye has been surgically removed. Given this limitation, we use aqueous humor (AH), the clear fluid in the front of the eye to detect specific markers, or information, that comes from the tumor itself.
Key Dates
- Start date
- Jan 1, 2017
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 800 participants (estimated)
Primary Outcome Measure
Correlation of Ocular Salvage (eye saved) with biomarkers [ Time Frame: through study completion, a minimum of 12 months after diagnosis and average of 24 months ]
Central Contacts
- Jesse L Berry, MD323-361-4510
Locations (8)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85016 | Jennifer Nguyen Merrylees Dersch, MD (PRINCIPAL_INVESTIGATOR) |
| Children's Hospital Los Angeles | Los Angeles | California | 90027 | |
| Emory University Children's Healthcare of ATL | Atlanta | Georgia | 30322 | Hans Grossniklaus, MD (PRINCIPAL_INVESTIGATOR) |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | Hanta Ralay-Ranaivo Janice Lasky-Zeid, MD (PRINCIPAL_INVESTIGATOR) |
| Oregon Health & Science University: Casey Eye Institute | Portland | Oregon | 97239 | Ann Lundquist Alison Skalet, M.D., Ph.D (PRINCIPAL_INVESTIGATOR) |
| Wills Eye Institute | Philadelphia | Pennsylvania | 19107 | Lisa Cotelesa Carol Shields, MD (PRINCIPAL_INVESTIGATOR) |
| St. Jude Children's Research Hospital | Memphis | Tennessee | 38105 | Dana Hawkins Matthew Wilson, MD (PRINCIPAL_INVESTIGATOR) |
| Seattle Children's Hospital; University of Washington | Seattle | Washington | 98101 | Jeff Stevens Andrew Stacey, M.D., M.S (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Phoenix, AZ
By research site
Phoenix Children's Hospital· Phoenix, AZChildren's Hospital Los Angeles· Los Angeles, CAEmory University Children's Healthcare of ATL· Atlanta, GAAnn & Robert H. Lurie Children's Hospital of Chicago· Chicago, ILOregon Health & Science University: Casey Eye Institute· Portland, ORWills Eye Institute· Philadelphia, PA
Related Studies
- Familial Investigations of Childhood Cancer PredispositionRecruiting · St. Jude Children's Research Hospital · Memphis, Tennessee
- Studying Health Outcomes After Treatment in Patients With RetinoblastomaRecruiting · Vanderbilt-Ingram Cancer Center · Chicago, Illinois
- GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic RetinoblastomaPHASE1 · Recruiting · Stephan Grupp MD PhD · Philadelphia, Pennsylvania
- Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.Recruiting · University of Washington · Seattle, Washington